期刊文献+

蠲痹伸筋汤治疗类风湿性关节炎的疗效观察 被引量:1

Clinical observation on treating RA with the Juanbi Shenjin decoction
下载PDF
导出
摘要 目的:观察蠲痹伸筋汤治疗类风湿性关节炎的临床疗效。方法:选择本院所收治的类风湿性关节炎患者80例,随机分为治疗组和对照组,每组40例。对照组口服甲氨蝶呤片治疗;治疗组在口服甲氨蝶呤片的基础上加服蠲痹伸筋汤治疗;两组患者均以4周为一个疗程,坚持治疗3个疗程,比较分析两组治疗前后临床疗效、症状体征积分以及实验室指标改善情况。结果:治疗组患者总体有效率(95%)高于对照组(75%),差异有统计学意义(P<0.05)。治疗组患者治疗第4周和第12周的症状体征积分以及实验室指标改善情况优于对照组,差异有统计学意义(P<0.05)。结论:蠲痹伸筋汤联合西药治疗类风湿性关节炎临床疗效确切,值得临床推广应用。 Objective:To observe the clinical effect of the Juanbi Shenjin decoction on rheumatoid arthritis.Methods:80patients were randomly divided into the treatment group and control group(n=40).The control group was treated with oral methotrexate tablets;the treatment group was treated with the Juanbi Shenjin decoction more,4weeks as a course,for3courses.The clinical efficacy,symptoms and signs in two groups were analyzed before and after treatment,and the improvement of laboratory indexes was analyzed.Results:The total efficiency(95%)was higher in the treatment group than75%in the control group(P<0.05).The improvement of symptoms and signs and the improvement of laboratory indexes in the treatment group were better than those in the control group at the4th week and the12th week(P<0.05).Conclusion:The Juanbi Shenjin decoction with western medicine on rheumatoid arthritis is effective and worthy of clinical application.
作者 周贯忠
出处 《中医临床研究》 2017年第8期104-106,共3页 Clinical Journal Of Chinese Medicine
关键词 蠲痹伸筋汤 甲氨蝶呤 类风湿性关节炎 中西医结合疗法 The Juanbi Shenjin decoction Methotrexate Rheumatoid arthritis The integrative medicine
  • 相关文献

参考文献2

二级参考文献14

  • 1Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatie drugs: 2013 update[J]. Ann Rheum Dis,2014, 73: 492-509.
  • 2Alamanos Y,Voulgari P V,Drosos A A. Incidence and prevalence of rheumatoid arthritis,based on the 1987 American College of Rheumatology criteria:a systematic review[J].Seminars in Arthritis and Rheumatism,2006,(03):182.
  • 3郑筱萸.中药新药治疗类风湿性关节炎的临床研究指导原则[S]北京:中国医药科技出版社,2002115.
  • 4Van Gestel A M,Prevoo M L,Van't Hof M A. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis.Comparison with the preliminary american College of Rheumatology and the world Health Organization/International League Against Rheumatism Criteria[J].ARTHRITIS AND RHEUMATISM,1996,(01):34.
  • 5Saag K G,Teng G G,Patkar N M. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis[J].ARTHRITIS AND RHEUMATISM,2008,(06):762.
  • 6程兆盛;王坤根;林志南.现代中成药[M]南昌:江西科学技术出版社,1997808.
  • 7何羿婷,查青林,喻建平,谭勇,吕诚,吕爱平.类风湿关节炎症状公因子与中西药疗效的关系[J].中西医结合学报,2008,6(1):32-36. 被引量:9
  • 8劳溢权,张继平,张波,姜剑英,廖永清,于新发,周成宇.益肾蠲痹丸对类风湿性关节炎活动期患者血清PAF含量的影响[J].新中医,2008,40(10):32-33. 被引量:9
  • 9雷玲,赵铖,米存东.类风湿关节炎病情活动指标与DAS28的相关性研究[J].广西医科大学学报,2008,25(6):893-895. 被引量:44
  • 10张良登,何庆勇,赵艳,张月.基于聚类分析的类风湿性关节炎活动期中医证候分类及其诊断研究[J].中国中医药信息杂志,2009,16(7):16-18. 被引量:8

共引文献101

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部